Trial Profile
Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2013
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 11 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2010 Planned end date (1 Jul 2010) added as reported by ClinicalTrials.gov.
- 11 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.